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to glutathione (GSH) and cystine to cysteine and decreased 
arginine synthesis with resultant decreased bioavailability of 
nitric oxide and reactive oxygen as a scavenger.[1,2]
Endogenous production of free radicals during cellular 
metabolism may be greatly enhanced by exogenous 
Introduction
Numerous reasons have been advanced for the increased 
oxidative stress in patients with chronic renal failure and 
hemodialysis. These include retention of phenol indoxyl 
carboxyl, methylguanidine metals, and oxidized lipids, which 
are oxidants or pro-oxidants and should be excreted in urine 
or eliminated.[1,2] Generalized deteriorations in renal metabolic 
activities, for instance, with reduction in glutathione disulfide 
Abstract
Background: Renal failure is accompanied by oxidative stress, which is caused by enhanced production of reactive 
oxygen species and impaired antioxidant defense.
Aim: To assess the effect of hemodialysis (by cellulose membrane dialyzer) on plasma total antioxidant status and lipid 
peroxidation of patients in chronic renal failure before and after dialysis.
Objective: The finding would serve as guide to administration or otherwise of supplementary therapeutic antioxidant 
before or after hemodialysis. Also, it will assist in the choice of antioxidant impregnated over the conventional non-
impregnated dialyzer membrane.
Materials and Methods: Twenty-five patients (14 men and 11 women, aged 24-75 years; median 61) with end-stage 
renal failure who were undergoing hemodialysis for the first time were recruited. Plasma level of potassium (K+), 
sodium (Na+), blood urea nitrogen (BUN), creatinine, total antioxidant status (TAS), and lipid peroxidation (MDA) were 
measured, before and after hemodialysis.
Results: The mean ± SD of plasma level of TAS (1.10 ± 0.3 mmol/L trolox Eq) for males and (1.09 ± 0.2 mmol/L trolox Eq) 
for females postdialysis were significantly reduced (P < 0.05) in comparison with (1.72 ± 0.4 mmol/L trolox Eq) for males and 
(1.83 ± 0.7 mmol/L trolox Eq) for females predialysis, respectively. However, the mean ± SD plasma level of MDA (6.03 ± 0.4 
nmol/ml) for males and (6.71 ± 0.7 nmol/ml) for females were significantly increased postdialysis (P < 0.01) compared to 
predialysis (3.98 ± 0.8 nmol/ml) for males and (4.05 ± 0.9 nmol/ml) for females, respectively.
Conclusions: Based on the outcome of this study, it is suggested that antioxidant-impregnated dialysis membranes 
and/or exogenous supplementary antioxidant would be beneficial to patients with chronic renal failure. Removal of 
reactive oxygen species could improve the health and general quality of life of uremic patients.
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factors like environmental pollutants, drugs, radiation, 
and pathogens.[3] An increased generation of free-
radicals has also been reported in several disease states 
such as atherosclerosis, diabetes mellitus, malignancy, 
cardiovascular disease, hepatobiliary, pulmonary and renal 
disorders, neurodegenerative diseases, and inflammatory 
and infectious diseases.[4] When free radical production 
exceeds the available antioxidant defenses, the excess 
radicals react with all classes of biological molecules such 
as lipids, polypeptides, and nucleic acid, causing lipid 
peroxidation, protein denaturation, and vascular injuries.[5]
Increased concentrations of malondialdehyde (MDA)—
intermediate product of oxidation of polyunsaturated fatty 
acids—have been reported in the plasma and erythrocytes, 
as well as in platelets and mononuclear cells of hemodialyzed 
patients.[6] Chronic renal failure is a pro-oxidant state, 
characterized by increased levels of free radical oxidants 
relative to antioxidants.[7] However, so far, it is not clear 
whether increased MDA is caused by the dialysis procedure 
or by the kidney disease itself. Some studies in hemodialyzed 
patients have investigated markers of oxidative stress such 
as MDA, or antioxidant defense systems such as SOD, GPx 
activity in erythrocytes, or free radical scavengers, eg, ascorbic 
acid, ß-carotene, and tocopherol. There are conflicting 
reports on a deficit in serum antioxidant vitamins and a 
decreased activity of erythrocyte antioxidant enzymes.[8-10]
Experimental and clinical studies have shown that in 
chronic renal failure, oxidative stress is a potentially 
important source of patient morbidity and mortality. It has 
also been implicated in the pathogenesis of atherosclerosis, 
malnutrition,[11] anemia,[12] dialysis-induced amyloidosis,[13] 
and, possibly, an increased risk of cancerogenesis,[14] in 
these patients. Various therapeutic interventions have 
been attempted to reduce oxidative stress in chronic renal 
failure so as to improve patient outcome.[15] Therapeutic 
approaches to reduce oxidative stress in patients with chronic 
renal failure are focused on reduction of inflammatory cell 
activation, removal of inflammatory mediators, and the use 
of antioxidants.[15]
Hemodialysis has been suggested to induce oxidative stress, 
with reactive oxygen species being generated on the surface 
of dialysis membranes by activation of polymorphonuclear 
leukocytes.[16] Indeed, some studies have shown that a single 
session of hemodialysis significantly increases lipid peroxides 
and decreases antioxidants.[17]
Some investigators have suggested that in order to 
attenuate the activation of polymorphonuclear leukocytes 
on the surface of dialysis membranes, the recently invented 
vitamin E-coated multilayer hemodialysis filter could be 
beneficial.[18,19] This device attenuates consumption of blood 
antioxidants, oxidative demolition of lipids, and activation 
of leukocytes.[18,19]
The aim of this study was to assess the effect of hemodialysis 
on plasma lipid peroxidation and antioxidant status before 
and after hemodialysis using the convectional cellulose 
membrane dialyzer. The observe effect of hemodialysis 
therapy on the oxidative markers may guide us in the use of 
alternative dialyzer membrane for a better result for patients 
undergoing dialysis.
Materials and Methods
The study was carried out at the Renal Unit of the General 
Hospital, Gbagada, and Lagos Island General Hospital, 
Lagos State, Nigeria, after the approval of the ethics 
committee of the state. A total of 25 patients (14 men 
and 11 women, aged 24-75 years; median 61) with end-
stage renal failure who were booked for hemodialysis were 
recruited in the study. The exclusion criteria were smoking, 
diabetes mellitus, patients with chronic inflammatory 
conditions, and hepatic or respiratory diseases. Those on 
antioxidant vitamin or fish-oil supplements were excluded. 
All patients were freshly booked for hemodialysis using the 
conventional cellulose membrane dialyzer.
Patients were fasted overnight, thereafter 10 ml of venous 
blood was taken at the antecubital fossa without stasis 
immediately and after hemodialysis. The venous blood was 
collected in lithium heparinized bottles.
The plasma samples obtained after centrifugation at 3500 rpm 
for 10 minutes were immediately stored at -20oC until they 
were analyzed. Sodium, potassium, and bicarbonate were 
estimated on the Ion Selective Electrode (ISE) equipment 
supplied by the ISN Nig Ltd. Plasma albumin, blood urea 
nitrogen (BUN), uric acid, and creatinine were estimated 
using standard method on Beckman synchron CX5 
automation analyzer supplied by Darlez Nig. Ltd. Vitamin 
E was determined with a fluorescence detector (2475 Multi 
Wavelength Fluorescence Detector, Waters, Eschborn, 
Germany) with 293 nm for excitation and 325 nm for 
emission. Peak areas were analyzed, and quantification was 
performed by calibration with external standards.
Measurement of MDA as secondary product of lipid 
peroxidation was employed to assess oxidative stress in this 
study. Estimation of MDA was done using the method of 
Satoh,[20] while measurement of total antioxidant status 
in the plasma was performed by using a method given 
in commercial kit from Randox Laboratories (Randox 
Laboratories Ltd, Diamond Road, Crumlin, Co. Antrim, 
Ireland).[21] Spectrophotometric measurements were done on 
the Spectronic 21D, the assay was calibrated using 6-hydroxy-
2,5,8-tetra-methylchroman-2-carboxylic acid (trolox). 
Results were expressed as mmol/L of trolox equivalent. All 
equipment used were routinely standardized. Universal 
quality control (precinorm and precipath materials were used 
at level I (normal range) and level II (pathological range).
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Statistical analysis
All data were expressed as the mean ± SD. Statistical 
analysis of the results was performed using SPSS for 
Windows version. Statistical significance was analyzed 
with paired Student’s t test. Correlations were performed 
by Pearson’s method. A value of P < 0.05 was considered 
statistically significant.
Results
A total of 25 patients with renal failure were recruited into 
the study. Of these, 14 were males, while 11 were female, with 
a male:female ratio of 1:0.9. [Table 1] shows the measured 
parameters before and after dialysis. All values were expressed 
as (mean ± SD). [Table 2] shows correlation values between 
measured parameters after dialysis with TAS and MDA.
In the male subjects, there was a significant decrease 
(P < 0.05) in plasma K+ level postdialysis (4.0 ± 0.5 mmol/L) 
compared to predialysis (5.7 ± 1.2 mmol/L). Similar result 
was seen in female subjects (3.8 ± 0.7 mmol/L) compared 
to (6.1 ± 1.5 mmol/L). However, in male subjects, there 
was significant increase (P < 0.01) in plasma HCO-3 level 
postdialysis (22.1 ± 4.7 mmol/L) compared to predialysis 
(17.1 ± 4.5 mmol/L); similarly, in female subjects 
(21.9 ± 5.1 mmol/L) compared to (15.5 ± 3.7 mmol/L).
The mean ±SD plasma BUN level postdialysis 
(17.2 ± 7.2 mmol/L) for male subjects and (19.1 ± 8.1 
mmol/L) for female subjects were significantly reduced 
(P < 0.001) compared to predialysis level of (40.6 ± 16.3 
mmol/L) and (43.1 ± 15.9 mmol/L), respectively. 
Similarly, the mean ±SD plasma creatinine level 
postdialysis (548.1 ± 229.8 umol/L) for male subjects 
and (572.5 ± 241.3 umol/L) for female subjects were 
significantly reduced (P < 0.001) compared to predialysis 
level of (1087.3 ± 424.2 umol/L) and (1079.5 ± 381.7 
umol/L), respectively.
The mean ±SD plasma TAS level postdialysis (1.10 ± 0.3 
mmol/L trolox Eq) for male subjects and (1.09 ± 0.2 mmol/L 
trolox Eq) for female subjects were significantly reduced 
(P < 0.05) compared to predialysis level of (1.72 ± 0.4 mmol/L 
trolox Eq) and (1.83 ± 0.7 mmol/L trolox Eq), respectively. 
However, the mean ±SD plasma MDA level postdialysis 
(6.03 ± 0.4 nmol/ml) for male subjects and (6.03 ± 0.4 
nmol/ml) for female subjects were significantly increased 
(P < 0.001) compared to predialysis level of (3.98 ± 0.8 
nmol/ml) and (4.05 ± 0.9 nmol/ml), respectively.
Table 1: Mean (±SD) plasma concentration of biochemical parameters in the predialysis state and the post dialysis 
state of the patients
Biochemical Parameters Male (n = 14) Female (n=11)
Predialysis Postdialysis P value Predialysis Postdialysis P value
Na+ (mmol/L) 132.6 ± 3.8 135.1 ± 4.6 0.3610 138.1 ± 4.1 132.9 ± 7.9 0.3490
K+ (mmol/L) 5.7 ± 1.2 4.0 ± 0.5 0.0380* 6.1 ± 1.5 3.8 ± 0.7 0.0309*
HCO-3 (mmol/L) 17.1 ± 4.5 22.1 ± 4.7 0.0096** 15.5 ± 3.7 21.9 ± 5.1 0.0072**
BUN (mmol/L) 40.6 ± 16.3 17.2 ± 7.2 0.0002*** 43.1 ± 15.9 19.1 ± 8.1 0.0003***
Creatinine (umol/L) 1087.3 ± 424.2 548.1 ± 229.8 0.0004*** 1079.5 ± 381.7 572.5 ± 241.3 0.0005***
Uric acid (mmol/L) 0.51 ± 0.018 0.32 ± 0.015 0.0071** 0.49 ± 0.012 0.33 ± 0.017 0.0083**
Albumin (g/L) 28.3 ± 5.10 43.7 ± 4.90 0.0085** 30.1 ± 4.30 44.9 ± 3.80 0.0091**
a-Tocopherol (µmol/L) 24.19 ± 1.78 15.37 ± 1.94 0.0069** 23.09 ± 1.51 13.97 ± 1.55 0.0058**
TAS (mmol/L) trolox Equivalent) 1.72 ± 0.4 1.10 ± 0.3 0.0482* 1.83 ± 0.7 1.09 ± 0.2 0.0412*
MDA (nmol/ml) 3.98 ± 0.8 6.03 ± 0.4 0.0068** 4.05 ± 0.9 6.71 ± 0.7 0.0089**
Significant level at the P < 0.001***, P < 0.01**, and P < 0.05*
Table 2: Correlation of plasma measured parameter in postdialysis with total antioxidant status (TAS) and lipid 
peroxidation (MDA) ‘r’
Male (n = 14) Female (n = 11)
TAS MDA TAS MDA
r value P value r value P value r value P value r value P value
Na+ (mmol/L) 0.017 0.493 0.009 0.735 0.010 0.610 0.007 0.691
K+ (mmol/L) +0.31 0.041* –0.42 0.025* +0.33 0.039* –0.38 0.031*
HCO-3 (mmol/L) –0.47 0.017* +0.49 0.015* –0. 41 0.028* +0.49 0.011*
BUN (mmol/L) +0.68 0.0095** –0.72 0.0079** +0.69 0.0091** –0.70 0.0073**
Creatinine (umol/L) +0.77 0.0064** –0.79 0.0058** +0.75 0.0062** –0.74 0.0063**
Uric acid (mmol/L) +0.51 0.010* –0.63 0.0098** +0.48 0.013* –0.57 0.0098**
Albumin (g/L) +0.35 0.037* –0.41 0.028* +0.28 0.047* –0.36 0.039*
Significant level at the P < 0.001***, P < 0.01**, and P < 0.05*
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In males with chronic renal failure, an inverse correlation 
was observed between TAS/HCO-3 (r = -0.47, P < 0.05); 
however, a direct correlation between TAS/K+ (r = +0.31, 
P < 0.05), TAS/BUN (r = +0.68, P < 0.01), and TAS/
creatinine (r = +0.77, P < 0.01) was observed. On the other 
hand, a direct correlation was noted between MDA/HCO-3
 
(r = +0.49, P < 0.05). However, an inverse correlation 
between MDA/K+ (r = -0.42, P < 0.05), MDA/BUN 
(r = −0.72, P < 0.01), and MDA/creatinine (r = −79, 
P < 0.01) was observed. Similarly, in females with chronic 
renal failure, an inverse correlation was observed between 
TAS/HCO-3 (r = −0.41, P < 0.5); however, a direct 
correlation between TAS/K+ (r = +0.33, P < 0.5), TAS/
BUN (r = +0.69, P < 0.01), and TAS/creatinine (r = +0.75, 
P < 0.01) was observed. On the other hand, a direct correlation 
was noted between MDA/HCO-3
 (r = +0.49, P < 0.05); 
however, an inverse correlation was observed between MDA/
K+ (r=−38, P < 0.5), MDA/BUN (r = −0.70, P < 0.01), 
and MDA/creatinine (r = −74, P < 0.01).
Discussion
Under normal conditions, there is a steady state balance 
between production of oxygen free radicals and their 
destruction by the cellular antioxidant systems. The oxygen 
free radicals, which accumulate via an imbalance between 
generation and scavenging, are behind the pathogenesis of 
many diseases.[4]
In recent years, numerous studies have focused on detection 
of signs of oxidative stress in renal patients. There is good 
evidence indicating that uremia is generally associated with 
enhanced oxidative stress. Treatment of uremic patients 
with hemodialysis or peritoneal dialysis has been suggested 
to particularly contribute to oxidative stress and reduced 
antioxidant levels in such patients. Hemodialysis membrane 
had been implicated in the induction and activation of 
macrophages on the surface of dialysis membranes during 
the dialysis session. This contributes to the oxidative 
stress. Loss or deficiency of antioxidant activity could also 
contribute to enhanced oxidative stress in patients with 
chronic renal failure.[22]
In this study, a significant increase in MDA was observed, 
which is the measurement of secondary products of lipid 
peroxidation and a significant decrease in total antioxidant 
status in chronic renal failure patient after dialysis. This 
finding supports most of the previously published findings 
that the hemodialysis procedure alters lipid peroxidation 
and the antioxidant status. Some researchers have 
reported increased status,[23] while some have recorded 
reduction,[24] and others were equivocal[25] on MDA levels 
after hemodialysis. However, using the high-performance 
liquid chromatography (HPLC) technique, Peuchant et al.
[26] reported low post-hemodialysis MDA in contrast to 
increased MDA reported in studies where less specific 
analytical techniques were used.[20] Virtually all studies 
yielded increased serum LDL cholesterol levels in patients 
with chronic renal failure.[27]
Our study demonstrated that predialysis patients had low 
MDA levels and high antioxidant status, but postdialysis 
(using convectional ordinary cellulose membrane dialyzer) 
samples gave an opposite levels of the analytes. In their 
study of patients with chronic renal failure that had 
peritoneal dialysis, Ülver et al.[28] observed high MDA 
levels and low antioxidant capacity. There seems to be 
no significant difference in the serum level of oxidative 
stress indices between peritoneal dialysis and hemodialysis 
patients regardless of the structure of the dialysis membranes 
used. The use of vitamin E-coated membranes could help 
minimize the increased oxidative stress and the attendant 
risk of atherosclerosis in dialysis patients. Mune et al.[27] 
have shown that the use of vitamin E-coated cellulose 
membrane dialyzers for 6 months resulted in a significant 
reduction in low density lipoprotein, oxidized-LDL, and 
eventually low peroxidation compared to the ordinary 
cellulose membrane dialyzer. In order to decrease membrane 
bioincompatibility, and thereby minimize oxidative stress 
in hemodialysis patients, more compatible filters have 
been elaborated. Preliminary characterization of vitamin 
E-coated membranes has shown decreased activation of 
polymorphonuclear cells and monocytes, lower free radical 
production, and high biocompatibility.
The effect of hemodailysis antioxidant status of patients 
with chronic renal failure is controversial. One school 
of thought believes that hemodialysis would aggravate 
oxidative stress due to activation of inflammatory cells 
caused by the use of bioincompatible membranes and net 
losses of soluble antioxidants in water,[29]or by generation 
of free radicals.[30] In such an environment, it is necessary 
to perform prospective studies on hemodialysis-treated 
patients with various antioxidants-coated membrane rather 
than the convectional ordinary cellulose membrane dialyzer 
currently in use.
Conclusions
The results of our study show a significant difference in 
antioxidant capacity between the pre- and postdialysis 
groups, and sex had no significant influence in our finding. 
Our study has showed that there is loss of antioxidant during 
the course of hemodialysis, probably through the dialyzer 
membranes or generation of free radicals on the surface of 
dialyzer membranes or both. The decreased antioxidant 
capacity could be related to increasing lipid peroxidation 
in hemodialysed patients. The nutritional status of 
patients going for hemodialysis could be a contributor; 
further assessment is needed since we are a third world 
country. This study provides evidence that further studies 
need to be conducted in the use of other biocompatible 
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or modify membrane dialyzers, especially antioxidants-
coated membrane dialyzers. In addition, exogenous 
supplementation of antioxidant in pre- and postdialysis 
may be helpful, but improving our dialysis technique for 
effective removal of reactive oxygen species is important 
for successful outcome of hemodialysis therapy.
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